종설

遲發性 内淋巴水腫

李相哲 1
Sang Cheol Lee 1
Author Information & Copyright
1仁濟大學校 釜山白病院 耳鼻咽喉科學教室
1Department of Otolaryngology, Pusan Paik Hospital, Inje University

© Copyright 1990 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: May 31, 2020

ABSTRACT

Delayed endolymphatic hydrops(DEH), a clinical entity which was described as a syndrome with the characteristic clinical findings such as rotatory vertigo or fluctuating hearing loss on the normal ear appearing a few years after unilateral severe sensori-neural hearing loss or total deafness.

DEH can be differentiated from Meniere’s disease, and was first reported simutaneously by Nadol et al and Wolfson et al in 1975, and was specified by Schuknecht in 1978.

Schuknecht, in 1985, classified DEH into 3 types ; 1) ipsilateral : rotatory vertigo only, 2) contralateral: rotatory vertigo with fluctuating hearing loss on the normal side, and 3) bilateral.

In many cases the hearing loss was caused by juvenile unilateral total deafness of unknown causes, viral diseases such as mumps, other postinflammatory or posttraumatically.

There is no tendency of rule in latency between hearing loss and vertigo or fluctuating hearing loss on opposite ear, and it is more than 10 years in many cases.

Diagnosis is made from history, clinical findings, audiologic and equilibrium function test.

Treatment is similiar to that of Meniere’s disease with conservative (vasodilators, autonomic nerve controlling drugs, steroid, antivertiginous drugs, low salt diet, etc) and surgical method (endolymphatic sac surgery or labyrinthine destruction) in case of no effect by conservative. But, in general, the result of treatment is poorer than in Meniere’s disease.



36권 4호 Quiz 및 정답, 해설

정답 ④

설하신경자극술의 핵심 치료 원리는 설하신경의 내측 분지를 선택적으로 
자극하여 이설근(genioglossus muscle)의 전방 돌출을 유도함으로써 
수면 중 상기도의 기능적 개방성을 유지하는 것이다. 기존 Inspire® 시스템은 
흡기 노력 감지 센서를 이용해 자극을 호흡 주기와 동기화하며, Nyxoah Genio® 
시스템은 양측 설하신경을 동시에 자극하는 무배터리 구조를 채택한 최신 장치이다. 
반면 Ansa cervicalis stimulation은 혀가 아닌 인두 구조물의 미측 견인을 통해 
상기도를 안정화시키는 다른 기전을 가진다.

 

* 당첨자 (1명)

이**    010-****-**61

 

응모해 주신 모든분들께 감사드립니다.

경품은 당첨자분들께 2.20(금)까지 개별 발송해 드리겠습니다.

 

임상이비인후과 편집위원회 


I don't want to open this window for a day.